| Page 2054 | Kisaco Research
 

Sam Al-Murrani

Managing Director
Babylon BioConsulting LLC

Babylon BioConsulting LLC is a human and animal health-based consultancy firm specializing in pre-revenue and early stage valuations of Animal Health and Biotech companies and providing clients with investor outreach, due diligence, business development and intangible asset management and valuation services. Dr. Sam Al-Murrani is also Managing Director for Bimini LLC, a privately owned manufacturer of pet dose-form health supplements and health treats.

Sam Al-Murrani

Managing Director
Babylon BioConsulting LLC

Sam Al-Murrani

Managing Director
Babylon BioConsulting LLC

Babylon BioConsulting LLC is a human and animal health-based consultancy firm specializing in pre-revenue and early stage valuations of Animal Health and Biotech companies and providing clients with investor outreach, due diligence, business development and intangible asset management and valuation services. Dr. Sam Al-Murrani is also Managing Director for Bimini LLC, a privately owned manufacturer of pet dose-form health supplements and health treats.

Dr. Al-Murrani has a B.Sc. in Animal Science from the University of Edinburgh and a Ph.D. in Immunology/Biochemistry from the Roslin Institute and the Department of Veterinary Pathology at the University of Edinburgh. He holds an M.B.A. in Finance from Baker University.

 

 

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division.

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron

Chairman of the Executive Board and CEO
Virbac Santé Animale

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

 

Sorina Casian Botez

Associate Director, Principal Investments
Eight Roads

As part of the Principal Investments team, Sorina drives the strategy for Eight Roads’ real estate portfolio and works with the management teams of healthcare portfolio investments and associated food and agriculture venture fund, Anterra Capital.

Sorina Casian Botez

Associate Director, Principal Investments
Eight Roads

Sorina Casian Botez

Associate Director, Principal Investments
Eight Roads

As part of the Principal Investments team, Sorina drives the strategy for Eight Roads’ real estate portfolio and works with the management teams of healthcare portfolio investments and associated food and agriculture venture fund, Anterra Capital.

 

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC

Matt Dobbs

Global Chief Medical Officer
Destination Pet LLC
 

Simon Innes

Chief Executive
CVS Group

Simon was appointed as Chief Executive in January 2004. Prior to this he was Chief Executive of Vision Express from 2000 to 2004, over which time he built the business up to £220m turnover and 205 practices, and reversed a loss-making position to create one of the most profitable corporate optical operators in the UK. The growth strategy that was successful at Vision Express is now being implemented in the veterinary industry by CVS.

Simon Innes

Chief Executive
CVS Group

Simon Innes

Chief Executive
CVS Group

Simon was appointed as Chief Executive in January 2004. Prior to this he was Chief Executive of Vision Express from 2000 to 2004, over which time he built the business up to £220m turnover and 205 practices, and reversed a loss-making position to create one of the most profitable corporate optical operators in the UK. The growth strategy that was successful at Vision Express is now being implemented in the veterinary industry by CVS.

Prior to Vision Express, Simon was on the board of Hamleys PLC as Operations Director and gained 10 years’ management experience at Marks & Spencer. He also served seven years in the British Army, achieving the rank of Captain in the Royal Engineers.

9.3 Rising Star Travel Grant
 

Manish Bharti

Sales Leader
UiPath

Manish Bharti is Sales Leader at UiPath. He brings in 21 years of global techno- businesses experiences with his current focus on working with large enterprises on their transformation journey involving RPA, Cognitive & AI.  

In his current role as a Revenue Officer, he is responsible for building top line revenues and drive customer acquisitions and delight. Manish is an alumnus of IIM-B & HBS

Manish Bharti

Sales Leader
UiPath

Manish Bharti

Sales Leader
UiPath

Manish Bharti is Sales Leader at UiPath. He brings in 21 years of global techno- businesses experiences with his current focus on working with large enterprises on their transformation journey involving RPA, Cognitive & AI.  

In his current role as a Revenue Officer, he is responsible for building top line revenues and drive customer acquisitions and delight. Manish is an alumnus of IIM-B & HBS

 

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne

Paulo Refinetti

Researcher
Ecole Polytechnique Federale Lausanne